# Octapharma to build $1.5B critical care manufacturing facility in Rock Hill, SC

Octapharma announced plans to build its first US manufacturing site in Rock Hill, South Carolina, a $1.5 billion project expected to create 1,500 jobs. The facility will produce plasma-derived therapies and trauma care products.

- Type: New facility
- Announced: 2026-07-29
- Where: Rock Hill, South Carolina, United States
- Value: $1.50B
- Jobs: 1,500
- Status: announced
- Products: plasma-derived therapies, bleeding management products, trauma care products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Octapharma](https://endata.com/companies/45434.md)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/octapharma-to-build-1-5-billion-state-of-the-art-critical-care-manufacturing-facility-in-rock-hill-sc-302838003.html), 2026-07-29: "Octapharma...has formally announced plans to establish its first-ever United States-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.